InvestorsHub Logo
Followers 42
Posts 5506
Boards Moderated 0
Alias Born 01/28/2010

Re: bgrass1 post# 1076

Tuesday, 05/29/2018 9:00:53 PM

Tuesday, May 29, 2018 9:00:53 PM

Post# of 1189
Now that the Amarantus tests like LymPro were taken back by Amarantus, Avant consists mostly of Theralink now, the product that came from the Theranostics company during the triple merger. And Ovadx the original Avant product is a footnote. Theranostics had some revenue. We don't know anymore because they have not filed financials for a while.

I don't know why the last CEO quit, but IMO I suspect he did not like the financial games being played on the company by other players like Amarantus CEO who was a director and other directors/basketball players. As a result serious dilution of the stock took place. Maybe the new CEO will clean up the slate, but who knows.

https://www.avantdiagnostics.com/product-pipeline

https://www.genomeweb.com/molecular-diagnostics/avant-completes-acquisitions-amarantus-theranostics-health#.Ww318EgvzIU

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.